A
3.48
0.20 (6.10%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Acurx Pharmaceuticals, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.0
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.00 |
|
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 10.95% |
| 机构持股比例 | 18.21% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Prospect Financial Services Llc | 30 Sep 2025 | 19,883 |
| Nbc Securities, Inc. | 30 Sep 2025 | 1,500 |
| Gps Wealth Strategies Group, Llc | 30 Sep 2025 | 1,225 |
| Cornerstone Planning Group Llc | 30 Sep 2025 | 67 |
| 52周波幅 | ||
| 中 | 31.00 (790.81%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 30 Sep 2025 | 31.00 (790.80%) | 购买 | 4.29 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合